This special issue was published on occasion of the 10th anniversary of the International Biotechnology Innovation Days (IBID) 2018, which took place at the Senftenberg campus of the Brandenburg University of Technology (BTU) Cottbus -Senftenberg, from the 23rd to the 25th of May 2018. The IBID was launched in 2003 under the name Senftenberger Innovationsforum. The open access conference attracted about 200 international delegates from research institutions, clinics, biotech and pharma industry. This year's conference was organized by the Institute of Biotechnology of the Brandenburg University of Technology Cottbus-Senftenberg, the BioResponse e.V. and the Cluster HealthCapital Berlin-Brandenburg, with support of the Technical University of Applied Sciences Wildau, the Helmholtz-Zentrum Geesthacht and the Brandenburg Medical School Theodor Fontane.The IBID 2018 event was dedicated to the latest developments in biomedical and translational research, medical bioinformatics and bioanalytics. A vast panorama of topics has been discussed, ranging from molecular biomarkers in translational medicine to tissue engineering and cell therapies. One session and one day of data science workshops was devoted to medical bioinformatics since big-data clinical studies employing electronic healthcare records (EHR) provide additional insight into biomedical research. They may even provide evidence for guiding therapy [1]. The data science workshops were also pre-meetings for the second edition of the Why R? 2018 conference (Wroclaw, Poland, 2nd-5th of July 2018).Many of the IBID 2018 topics are covered in this special issue that includes one concept study, seven primary studies, and two reviews.Rosanski et al.[2] describe the knockout of proteolytic key regulators in malignant peripheral nerve sheath tumor cells with a special regard to the multifunctional proteasome activator PA28␥. The authors made use of the clustered regulatory interspaced short palindromic repeats (CRISPR)/Cas9 system; this method of genome editing has been one of the fastest growing areas in biotechnology for decades [3]. Application of microbeads and microscopic technologies suitable for point-of-care diagnostics play an increasing role in modern biotechnological techniques. Jurischka et al. [4] present a universal detection method for biomolecules using tyramide signal amplification (TSA) on the surface of proteincoated microbeads. In detail, they focus on the E6:E7 region of the high-risk human papillomavirus 16 (HPV-16). This method is potentially useful for the development of novel multiplex microbead assays. Another innovative analytical method was discussed by the work of Kagel et al. [5]. The authors review the application of photoacids as non-invasive control for biochemical reactions. Photoacids are molecules that become acid upon absorption of light and might bear great potential for future applications in biotechnology and biochemistry.In the field of cell and tissue engineering, three-dimensional cell growth, protein scaffolds as well as sample...